Oxford Capital Partners

Oxford Capital Partners, established in 1999, is a London and Oxford-based venture capital firm specialising in early-stage technology investments. The company focuses on backing high-potential start-ups in sectors such as mobility, fintech, insurtech, retail, digital marketplaces, digital health, artificial intelligence, and machine learning, with a diversified portfolio approach.

David Brister

Operating Partner

Edward Mott

Chairman

David Mott

Founder Partner

Richard Oakley

Investment Manager

Chris Payne

Investment Manager

Andrew Sherlock

Partner

Past deals in Pest Control

Exosect

Venture Round in 2015
Exosect Limited is a technology company based in Winchester, United Kingdom, founded in 1999 as a spin-out from the University of Southampton. The company specializes in developing innovative delivery platforms that enhance the effectiveness of pesticide formulations, addressing challenges such as pest resistance, regulatory compliance, and food chain residues. Its primary offerings include the Entostat delivery platform, which utilizes an electrostatically charged micro powder for microencapsulation and targeted release of active ingredients, and the Entomag delivery platform, a ferrous micro powder designed for the precise delivery of synthetic chemicals to control crawling insects, particularly in public health applications. With a strong portfolio of 41 patents and 28 national product registrations, Exosect is well-equipped to commercialize its patented technologies across agriculture, public health, and animal health sectors, contributing to the protection of food from pests and diseases.

Oxitec Limited

Venture Round in 2014
Oxitec Limited is a biotechnology company that develops genetic solutions for controlling insects that transmit diseases and damage crops. It uses the Sterile Insect Technique (SIT) enhanced with genetics and molecular biology to create self-limiting insect strains, aiming to reduce populations of pests such as mosquitoes and moths in an environmentally friendly manner.

Exosect

Venture Round in 2013
Exosect Limited is a technology company based in Winchester, United Kingdom, founded in 1999 as a spin-out from the University of Southampton. The company specializes in developing innovative delivery platforms that enhance the effectiveness of pesticide formulations, addressing challenges such as pest resistance, regulatory compliance, and food chain residues. Its primary offerings include the Entostat delivery platform, which utilizes an electrostatically charged micro powder for microencapsulation and targeted release of active ingredients, and the Entomag delivery platform, a ferrous micro powder designed for the precise delivery of synthetic chemicals to control crawling insects, particularly in public health applications. With a strong portfolio of 41 patents and 28 national product registrations, Exosect is well-equipped to commercialize its patented technologies across agriculture, public health, and animal health sectors, contributing to the protection of food from pests and diseases.

Exosect

Venture Round in 2012
Exosect Limited is a technology company based in Winchester, United Kingdom, founded in 1999 as a spin-out from the University of Southampton. The company specializes in developing innovative delivery platforms that enhance the effectiveness of pesticide formulations, addressing challenges such as pest resistance, regulatory compliance, and food chain residues. Its primary offerings include the Entostat delivery platform, which utilizes an electrostatically charged micro powder for microencapsulation and targeted release of active ingredients, and the Entomag delivery platform, a ferrous micro powder designed for the precise delivery of synthetic chemicals to control crawling insects, particularly in public health applications. With a strong portfolio of 41 patents and 28 national product registrations, Exosect is well-equipped to commercialize its patented technologies across agriculture, public health, and animal health sectors, contributing to the protection of food from pests and diseases.

Oxitec Limited

Venture Round in 2012
Oxitec Limited is a biotechnology company that develops genetic solutions for controlling insects that transmit diseases and damage crops. It uses the Sterile Insect Technique (SIT) enhanced with genetics and molecular biology to create self-limiting insect strains, aiming to reduce populations of pests such as mosquitoes and moths in an environmentally friendly manner.

Exosect

Venture Round in 2012
Exosect Limited is a technology company based in Winchester, United Kingdom, founded in 1999 as a spin-out from the University of Southampton. The company specializes in developing innovative delivery platforms that enhance the effectiveness of pesticide formulations, addressing challenges such as pest resistance, regulatory compliance, and food chain residues. Its primary offerings include the Entostat delivery platform, which utilizes an electrostatically charged micro powder for microencapsulation and targeted release of active ingredients, and the Entomag delivery platform, a ferrous micro powder designed for the precise delivery of synthetic chemicals to control crawling insects, particularly in public health applications. With a strong portfolio of 41 patents and 28 national product registrations, Exosect is well-equipped to commercialize its patented technologies across agriculture, public health, and animal health sectors, contributing to the protection of food from pests and diseases.

Exosect

Venture Round in 2011
Exosect Limited is a technology company based in Winchester, United Kingdom, founded in 1999 as a spin-out from the University of Southampton. The company specializes in developing innovative delivery platforms that enhance the effectiveness of pesticide formulations, addressing challenges such as pest resistance, regulatory compliance, and food chain residues. Its primary offerings include the Entostat delivery platform, which utilizes an electrostatically charged micro powder for microencapsulation and targeted release of active ingredients, and the Entomag delivery platform, a ferrous micro powder designed for the precise delivery of synthetic chemicals to control crawling insects, particularly in public health applications. With a strong portfolio of 41 patents and 28 national product registrations, Exosect is well-equipped to commercialize its patented technologies across agriculture, public health, and animal health sectors, contributing to the protection of food from pests and diseases.

Oxitec Limited

Venture Round in 2011
Oxitec Limited is a biotechnology company that develops genetic solutions for controlling insects that transmit diseases and damage crops. It uses the Sterile Insect Technique (SIT) enhanced with genetics and molecular biology to create self-limiting insect strains, aiming to reduce populations of pests such as mosquitoes and moths in an environmentally friendly manner.

Oxitec Limited

Venture Round in 2009
Oxitec Limited is a biotechnology company that develops genetic solutions for controlling insects that transmit diseases and damage crops. It uses the Sterile Insect Technique (SIT) enhanced with genetics and molecular biology to create self-limiting insect strains, aiming to reduce populations of pests such as mosquitoes and moths in an environmentally friendly manner.

Exosect

Venture Round in 2009
Exosect Limited is a technology company based in Winchester, United Kingdom, founded in 1999 as a spin-out from the University of Southampton. The company specializes in developing innovative delivery platforms that enhance the effectiveness of pesticide formulations, addressing challenges such as pest resistance, regulatory compliance, and food chain residues. Its primary offerings include the Entostat delivery platform, which utilizes an electrostatically charged micro powder for microencapsulation and targeted release of active ingredients, and the Entomag delivery platform, a ferrous micro powder designed for the precise delivery of synthetic chemicals to control crawling insects, particularly in public health applications. With a strong portfolio of 41 patents and 28 national product registrations, Exosect is well-equipped to commercialize its patented technologies across agriculture, public health, and animal health sectors, contributing to the protection of food from pests and diseases.

Exosect

Venture Round in 2008
Exosect Limited is a technology company based in Winchester, United Kingdom, founded in 1999 as a spin-out from the University of Southampton. The company specializes in developing innovative delivery platforms that enhance the effectiveness of pesticide formulations, addressing challenges such as pest resistance, regulatory compliance, and food chain residues. Its primary offerings include the Entostat delivery platform, which utilizes an electrostatically charged micro powder for microencapsulation and targeted release of active ingredients, and the Entomag delivery platform, a ferrous micro powder designed for the precise delivery of synthetic chemicals to control crawling insects, particularly in public health applications. With a strong portfolio of 41 patents and 28 national product registrations, Exosect is well-equipped to commercialize its patented technologies across agriculture, public health, and animal health sectors, contributing to the protection of food from pests and diseases.

Exosect

Venture Round in 2008
Exosect Limited is a technology company based in Winchester, United Kingdom, founded in 1999 as a spin-out from the University of Southampton. The company specializes in developing innovative delivery platforms that enhance the effectiveness of pesticide formulations, addressing challenges such as pest resistance, regulatory compliance, and food chain residues. Its primary offerings include the Entostat delivery platform, which utilizes an electrostatically charged micro powder for microencapsulation and targeted release of active ingredients, and the Entomag delivery platform, a ferrous micro powder designed for the precise delivery of synthetic chemicals to control crawling insects, particularly in public health applications. With a strong portfolio of 41 patents and 28 national product registrations, Exosect is well-equipped to commercialize its patented technologies across agriculture, public health, and animal health sectors, contributing to the protection of food from pests and diseases.

Oxitec Limited

Venture Round in 2007
Oxitec Limited is a biotechnology company that develops genetic solutions for controlling insects that transmit diseases and damage crops. It uses the Sterile Insect Technique (SIT) enhanced with genetics and molecular biology to create self-limiting insect strains, aiming to reduce populations of pests such as mosquitoes and moths in an environmentally friendly manner.

Oxitec Limited

Venture Round in 2005
Oxitec Limited is a biotechnology company that develops genetic solutions for controlling insects that transmit diseases and damage crops. It uses the Sterile Insect Technique (SIT) enhanced with genetics and molecular biology to create self-limiting insect strains, aiming to reduce populations of pests such as mosquitoes and moths in an environmentally friendly manner.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.